When an established medical device moves to a new manufacturing partner, every detail matters. Drawings, BOMs, work instructions, supplier requirements, validation records, and quality expectations all need to be reviewed, translated, and controlled before production can scale. A successful product transfer protects more than output. It protects product performance, compliance, supply continuity, and the OEM’s confidence in long-term manufacturing stability.
What this article explains:
You will learn what OEMs should know before transferring medical device production. A medical device product transfer is more than moving drawings, BOMs, and work instructions to a new supplier. OEMs need a contract manufacturing partner that can review documentation, assess production risk, validate processes, verify supplier controls, maintain traceability, and protect long-term supply continuity. This article explains the key steps OEMs should address before transferring production to a new medical device contract manufacturer.
Planning a product transfer? Sanbor Medical can help OEMs move established medical devices into controlled, repeatable, and scalable production environments.
Whether the goal is to improve capacity, reduce manufacturing risk, strengthen quality systems, support regional production, or move production from an underperforming supplier, a successful medical device product transfer requires more than technical documentation. It requires a manufacturing partner that can translate product knowledge into a stable, repeatable, and compliant production process.
For OEMs, the value of a successful transfer is clear: protect the original design intent, maintain product performance, improve manufacturing efficiency, and create a more reliable foundation for full-scale production.
With the FDA’s Quality Management System Regulation now incorporating ISO 13485:2016 into 21 CFR Part 820, effective February 2, 2026, medical device manufacturers are operating in an environment where documented quality systems, production controls, risk management, traceability, and transfer discipline are more important than ever.
A medical device product transfer often happens after a device has already moved beyond initial development. The OEM may have validated the product, established specifications, and commercialized the device, but now needs to move manufacturing to a new partner.
That transfer may be driven by:
In each case, the challenge is not simply to copy the existing process. The challenge is to understand the product, identify transfer risks, rebuild or improve the production system, and prove that the new manufacturing process can consistently meet the device’s requirements.
That is where the right medical device contract manufacturer can create measurable value.
At Sanbor Medical, product transfer is approached as a controlled manufacturing readiness process. The goal is not only to receive the product package, but to convert it into a repeatable, traceable, and scalable production operation that supports OEM quality, compliance, and supply chain goals.
A successful transfer begins with early and detailed alignment. Before production can move, both the OEM and contract manufacturer must establish a shared understanding of the product, specifications, quality expectations, regulatory requirements, production history, and known manufacturing risks.
This includes reviewing:
This early alignment helps prevent assumptions from becoming production problems. It also gives the contract manufacturer an opportunity to identify gaps, clarify requirements, and recommend improvements before the transfer moves too far forward.
For Sanbor Medical, this is where collaboration becomes critical. OEMs need a manufacturing partner that can ask the right questions, understand the product’s intended use, review manufacturability, evaluate process controls, and identify opportunities to strengthen production before volume manufacturing begins.
One of the most important steps in medical device product transfer is transforming the OEM’s product documentation into a complete production-ready manufacturing package.
Drawings, BOMs, and specifications are essential, but they are only part of the transfer. A contract manufacturer must convert those inputs into a controlled production system that operators, quality teams, and supply chain teams can execute consistently.
That may include:
ISO 13485:2016 includes requirements for documented design and development transfer procedures to verify that outputs are suitable for manufacturing and that production capability can meet product requirements. The FDA’s QMSR now incorporates ISO 13485:2016 into the U.S. device quality system framework.
For OEMs, this matters because an incomplete or ambiguous transfer package can lead to inconsistent builds, quality escapes, delays, rework, or regulatory exposure. The right manufacturing partner helps close these gaps before they become production risks.
Traceability is central to a successful medical device transfer. The OEM must be able to connect product requirements to manufacturing controls, inspection records, component history, and finished device documentation.
A strong product transfer process should establish traceability across:
This traceability helps ensure that the device being manufactured by the new contract manufacturer reflects the correct design intent, approved specifications, and quality requirements.
It also supports faster issue investigation. If a defect, supplier issue, or process deviation occurs, traceability allows the OEM and manufacturer to identify affected lots, determine root cause, and implement corrective action more effectively.
For Sanbor Medical customers, traceability is not treated as an administrative requirement. It is part of building confidence in every production run.
Medical device risk management does not end once the product is designed. During product transfer, known design risks, critical dimensions, functional requirements, and safety-related characteristics must be translated into manufacturing controls.
That means the contract manufacturer should review how product risks connect to:
This is where tools such as PFMEA and control plans become especially important. The goal is to make sure that known product risks are not only understood but actively controlled in production.
For example, a critical functional test should not simply appear at the end of the production process. The process should be structured so that upstream assembly, inspection, and handling steps reduce the risk of failure before final testing occurs.
A strong contract manufacturer can help OEMs improve this connection between product risk and production control. In many transfers, this is where meaningful improvements are made compared to the previous manufacturing arrangement.
Process validation is one of the most important proof points in a medical device product transfer. The OEM and contract manufacturer must demonstrate that the new production process can consistently manufacture products that meet requirements.
Depending on the product and process, this may involve:
The validation approach should be based on product risk, process complexity, and regulatory requirements. It should also account for worst-case conditions where appropriate, rather than only proving that the process works under ideal circumstances.
For OEMs, the validation report is evidence that the transferred process is ready for controlled production.
Sanbor Medical supports OEMs by helping convert product requirements into validated production processes that are documented, repeatable, and aligned with medical device quality expectations.
Product transfer is also an opportunity to evaluate and improve the supply chain.
A medical device can only be as reliable as the materials, components, and suppliers behind it. During transfer, the manufacturer should review whether current suppliers are approved, whether materials are available, whether certifications are complete, and whether any components create risk for long-term production.
Key supply chain activities may include:
This is especially important for OEMs transferring products because supply chain assumptions from the previous manufacturer may not automatically carry over. Components may need to be requalified, suppliers may need to be reviewed, and alternate sourcing strategies may need to be developed.
With Sanbor Medical, OEMs gain a manufacturing partner focused on both production execution and long-term supply security. The transfer process can uncover opportunities to improve sourcing, reduce risk, and support more predictable production.
Once a product is transferred and approved for production, change control becomes critical.
The OEM and contract manufacturer should clearly define how future changes will be reviewed, approved, documented, and implemented. This should be addressed through a quality agreement and supported by formal change control procedures.
Change control should apply to:
Without clear change control, even small adjustments can create quality or compliance risk. For medical device OEMs, the goal is to ensure that any change affecting the product, process, or supply chain is properly evaluated before implementation.
Sanbor Medical works with OEMs to support disciplined change management, helping protect product integrity throughout the full manufacturing life cycle.
A product transfer should not simply recreate the same manufacturing process in a new location. With the right partner, it can become an opportunity to improve the production system.
Sanbor Medical helps OEMs identify opportunities such as:
These improvements can help OEMs move beyond the limitations of their previous manufacturing setup and establish a stronger foundation for future production.
Sanbor Medical has long supported OEM production of medical devices and related systems, including products such as pulmonary function devices, human organ transportation systems, cell culture instruments, orthopedic devices, and other regulated medical products.
Our role is not limited to building products. We help OEMs transfer, stabilize, validate, and scale production with the documentation, quality systems, and manufacturing discipline required in the medical device industry.
A successful transfer gives OEMs more than a new supplier. It provides confidence in:
A successful medical device product transfer is a structured process that requires collaboration, technical review, risk management, validation, supplier alignment, traceability, and disciplined change control.
For OEMs, the right contract manufacturing partner can make the difference between a transfer that creates disruption and a transfer that strengthens the entire manufacturing program.
Sanbor Medical helps OEMs move established medical device products into controlled, repeatable, and scalable production environments. By combining manufacturing experience, quality system discipline, and a strong understanding of OEM expectations, Sanbor Medical helps deliver more than finished products.
With a solid manufacturing partner, product transfer becomes an opportunity to strengthen quality, improve production confidence, and build a more reliable path for long-term medical device manufacturing.
Medical device product transfer is the controlled process of moving production of an established medical device to a new manufacturing environment. It includes reviewing product documentation, validating production processes, verifying supplier controls, maintaining traceability, and ensuring the new manufacturer can consistently meet product and quality requirements.
OEMs may transfer medical device production to improve capacity, reduce supply chain risk, address quality or delivery issues, support regional manufacturing, consolidate suppliers, improve cost control, or strengthen documentation and process validation.
Common documents include product drawings, BOMs, specifications, work instructions, test procedures, inspection plans, packaging requirements, labeling requirements, validation records, supplier documentation, quality agreements, production history, and change history.
Process validation helps prove that the new manufacturing process can consistently produce devices that meet approved specifications and quality requirements. Depending on the product and process, validation may include IQ, OQ, PQ, first article inspection, pilot builds, functional testing, and packaging verification.
Traceability connects product requirements, drawing revisions, components, suppliers, process steps, inspection records, and finished device documentation. This helps OEMs investigate issues, control changes, verify compliance, and protect product quality after transfer.
The right contract manufacturer can identify documentation gaps, improve work instructions, strengthen inspection points, support process validation, enhance supplier controls, reduce production variation, and create a more repeatable manufacturing process.
